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Edited by Beat ImhofAbstract Ulcerative colitis (UC) is a chronic inﬂammatory
bowel disease with mucosal inﬂammation and ulceration of the
colon. There seems to be no single etiological factor responsible
for the onset of the disease. Autoimmunity has been emphasized
in the pathogenesis of UC. Perinuclear anti-neutrophil cytoplas-
mic antibodies (pANCA) are common in UC, and recently two
major species of proteins immunoreactive to pANCA were de-
tected in bacteria from the anaerobic libraries. This implicates
colonic bacterial protein as a possible trigger for the disease-
associated immune response. Autoantibodies and T-cell response
against human tropomyosin isoform 5 (hTM5), an isoform pre-
dominantly expressed in colon epithelial cells, were demonstrated
in patients with UC but not in Crohns colitis. We identiﬁed two
bacterial protein sequences in NCBI database that have regions
of signiﬁcant sequence homology with hTM5. Our hypothesis is
that molecular mimicry may be responsible for the pathogenesis
of UC.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Autoimmune diseases are a challenge not only to the pa-
tients suﬀering but also to the researchers trying to understand
their etiology and biology. When the answers for the cause of
autoimmune diseases are being sought, the microbial kingdom
seems to be the place to look for trouble makers. The obser-
vation that infection can precipitate an autoimmune disease
dates back to more than a century [1]. Paroxysmal cold hemo-
globulinuria, and rheumatic fever are a couple of important
examples in support of this notion. It is well established that
autoreactive T and B cells exist in the blood of healthy individ-
uals and these cells can potentially induce autoimmunity if
activated beyond certain thresholds [2]. In ﬁghting the infec-
tion, the immune system must discriminate between self and
a pathogen to destroy pathogen without destroying its host.
Discrimination between self and non-self is critical for theAbbreviations: UC, ulcerative colitis; TM, tropomyosin; MHC, major
histocompatibility complex
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doi:10.1016/j.febslet.2005.02.073maintenance of ﬁne balance of human immune system. An er-
ror in judgment could lead to self-destruction of host cells.
Infection with certain parasites, bacteria, viruses, mycobacte-
ria, and yeast can potentially induce autoimmunity [2].
The concept of molecular mimicry states that antigenic
determinants of infectious microorganisms resemble structures
in the tissue of the host but diﬀer enough to be recognized as
foreign by the host immune system [1]. The initial support
for the suggestion that molecular mimicry might play a role
in autoimmune disease was found in 1983 when the antibody
against the phosphoprotein of measles virus and Herpes sim-
plex type I cross-reacted with an intermediated ﬁlament pro-
tein, vimentin, of human cells [3].2. Infectious etiology of autoimmune diseases
It is known that autoreactive T and B cells exist in the blood
of healthy individuals [4,5], but why only in certain individuals
these cells cause autoimmunity? Infectious agents are recog-
nized to be likely candidates in altering the balance in immu-
no-regulatory processes which could break self-tolerance.
Some of the autoimmune diseases that are linked to bacterial
pathogens are rheumatoid arthritis [6–8], Graves disease
[9,10], ankylosing spondylitis [11,12], systemic lupus erythe-
matosus [13–15] and insulin dependent diabetes mellitus
[16,17].
Do the bacteria/viral infections initiate/cause autoimmune
diseases or they are the proverbial last straw that tilt the bal-
ance from tolerance to defense? Or, is it an attack that is a nat-
ural mechanism of self-preservation devised by the body? The
answers may be speciﬁc to the individual diseases. It has been
generally believed that microbial pathogens could be initiators
and propagators of a number of autoimmune diseases. For
example, in Chagas disease, the presence of cardiac inﬂamma-
tory inﬁltrate in apparent absence of Trypanosoma cruzi para-
site suggests that the trypanosome initiates an autoimmune
response [18].
The autoimmune diseases could be viewed as cases of mis-
taken identity. In the era of genomics and proteomics and in
the realm of molecular and structural basis of human diseases,
it is hard to ignore the role of molecular twins or structural
dupes that could play a trick on the unsuspecting host immune
system. We may also consider the microbial peptides/proteins
as molecular con artists. It is a philosophical issue as to
whether the microbes pro-actively attack the immune system
or the host immune system over reacts in its eﬀorts to preserve
its identity. Nevertheless, the consequence is a chronicblished by Elsevier B.V. All rights reserved.
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disease rather than the symptoms, there is a need to identify
the factors and facilitators of pathogenesis and to pursue the
ultimate goal of suggesting and identifying the targets for drug
discovery to cure the disease.Fig. 1. Role of molecular mimicry in infection mediated autoimmune
disease. Food-borne infection with bacteria leads to diarrhea. The host
mounts an adaptive immune response towards bacterial antigens.
Under the inﬂuence of host-related factors, such as polymorphisms in
immune response genes and priming of the immune system by previous
or concomitant infections, the immune response is diverted and high
titer cross-reactive antibodies against bacterial antigens are produced.
Abbreviations: APC, antigen presenting cell. (The schematic is adapted
from [65].)3. Mechanisms of infection-mediated autoimmunity
Infectious agents can participate in any three stages of auto-
immune diseases: Initiation, propagation, and tissue destruc-
tion. How can infection trigger or exacerbate autoimmunity?
There are three attractive hypotheses: the molecular mimicry
hypothesis suggests shared epitopes between the host and
pathogen that can either elicit autoreactivity or allow the
organism to persist in the host by evading immune recognition.
The autoreactive memory T-cells can respond to subsequent
infection or environmental factors and can induce long-term
damage to the host organ having the cross-reactive epitopes.
Fig. 1 presents a schematic of the mechanisms of molecular
mimicry in infection mediated autoimmune processes. The sec-
ond hypothesis proposes that the immune response elicited by
the infection can cause upregulation of chaperones, heat shock
proteins, and major histocompatibility complex (MHC) mole-
cules, resulting in abnormal processing and presentation of
sequestered self-antigens. The third hypothesis involves a newly
characterized class of bacterial proteins called superantigens
which are inducers of inﬂammatory reactions and potentially
cause expansion of autoreactive T cells.
According to the molecular mimicry hypothesis, the pres-
ence of shared and/or cross-reactive epitopes between the host
and the pathogen may induce autoaggression by evoking auto-
reactive T and B cells. The response to a dominant microbial
epitope may evoke an immune response to a cross-reactive
cryptic self-epitope. Alternatively, molecular mimicry may al-
low the organism to evade immune elimination and survive
in the host, causing damage by unknown mechanisms. Molec-
ular mimicry is thought to account for numerous infection-
associated autoimmune disorders ([19,20] and Table 1). These
include the post-streptococcal autoimmune disease in which
epitopes shared between the bacterial M protein as well asTable 1
Examples of infectious etiology of some autoimmune diseases
Immune-mediated disease Microbe/antigen
Graves disease Thyrotropin receptor
Ankylosing spondylitis Klebsiella pneumoniae, pulD secretion pr
Systemic lupus erythematosus Epstein–Barr virus nuclear antigen-1 (E
Insulin-dependent diabetes Coxsackie virus B4, protein P2-c; cytome
islet antigens (GAD 65, proinsulin carbo
Behcets syndrome a-TM
Lyme arthritis Borrelia burgdorferi, OSP-A
Acute rheumatic fever Group A streptococci, M-protein
Chagas disease Trypanosoma cruzi, B13 protein
Multiple sclerosis Myelin proteins, corona, measles, mump
Myocarditis Coxsackie B3, streptococci, ADP/ATP c
Guillain–Barre´ syndrome Campylobacter jejuni, peripheral nerve g
Myasthenia gravis Herpes, acetylcholine receptor
Celiac Adenoviruses, enteric microbes, gliadin
Autoimmune uveitis Viruses, S-antigen
Peptic ulcer/gastric CA H. pylori, self-antigens on gastric mucos
Primary biliary cirrhosis Pyruvate dehydrogenase complex Anti-m
Rasmussens encephalitis Microorganisms: E. coli, S. cerevisial an
Rheumatoid arthritis Proteus mirabilis, ESRRAL peptideother surface proteins and a number of host proteins such as
myosin, tropomyosin (TM), vimentin, and lamimin have been
described [21–24]. The initiation of an autoimmune response
requires that the immune system receives two signals – one is
antigen speciﬁc and the other is non-antigen speciﬁc. The anti-
gen may be provided by a virus or a bacterium in molecular
mimicry. Human populations that are exposed to high patho-
gen loads have a much lower incidence of autoimmunity than
their pathogen-free counterparts probably due to develop-
ment of tolerance [25].4. Is amino acid sequence similarity critical to molecular
mimicry?
Antigenic mimicry was thought to be primarily limited to
epitopes that shared a noticeable degree of chemical similarity;
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tiﬁed from databases. There seems to be a view that topologi-
cal considerations that invoke the classical examples of lock
and key mechanism are universal. The notion what ﬁts, ﬁts,
irrespective of the sequence [27] suggests a possibility that con-
formational mimicry may be more relevant than antigen mim-
icry. However, the reality could be somewhere in between. The
proposition that peptide sequence bears a signature for im-
mune response and any other peptide that mimics its structure
can elicit similar response seems to generate a debate much the
same way as the suggestion by Anﬁnsen [28], when he sug-
gested that the amino acid sequence of a protein dictates its
three dimensional structure. In an interesting report, Jones
et al. [29] catalogued human heat shock proteins that have sim-
ilarity to known autoantigens suggesting that sequence similar-
ity may be necessary but not a suﬃcient criteria.
It is a common fact that the sequence is critical for the func-
tional three-dimensional structure of proteins, and chaperones
aid the process of folding into functionally active structures.
Similarly, it seems likely that while the amino acid sequence
of peptide is important for immune response, the adjuvant,
the immunological equivalents of chaperones, play crucial role
in shaping the antigens to be immunogenic. The fact that
microbial peptides with limited sequence homology with mye-
lin basic protein can activate T cell response seems to suggest a
possibility that molecular mimicry could include conforma-
tional mimicry as well [27]. On the other hand, signiﬁcant se-
quence similarity could qualify a peptide/protein to be a
better molecular mimic or a conformational mimic. Two
types of signals are important for the generation of immune re-
sponse: (1) antigen speciﬁc recognition through T-cell and B
cell receptors, and (2) a number of non-antigen speciﬁc non-
clonal signals. It is possible that an infectious agent may pro-
vide the speciﬁc signals by molecular/conformational mimicry
or release endogenous antigen. The microbial agents seems to
trigger autoimmune response by providing adjuvant milieu in
the form of upregulation of co-stimulatory molecules and
other factors related to inﬂammation. For example, activation
of antigen presenting cells during microbial infection upregu-
lates co-stimulatory molecules and results in secretion of
inﬂammatory cytokines.Fig. 2. Alignment of amino acid sequences of peptides from hTM5
with the uncharacterized protein from Nostoc punctiforme (A), and a
sensor protein VanS from Bacillus cereus (B).5. Is ulcerative colitis an autoimmune disease?
The answer seems to be equivocal with suggestions and evi-
dence on both sides. However, what seems to be unequivocal is
that there may not be one single etiological factor responsible
for the onset and perpetuation of the disease [30–32]. The fact
that UC patients are prone to ﬂare-ups suggest a possible role
for bacteria in the disease process. Furthermore, as UC is a
chronic disease as opposed to infectious colitis, it is tantalizing
to postulate that the host immune system initiates a panic reac-
tion due to signals emanating from bacteria because of shared
molecular identity. Are bacteria responsible for the pathogen-
esis of UC or do they take advantage of vulnerable immune
system to initiate the disease process and generate symptoms.
Perinuclear anti-neutrophil cytoplasmic antibodies (pANCA)
are common in UC [33,34] and pANCA is recently shown to
detect a protein epitope expressed by colonic bacteria and thus
implicates colonic bacterial proteins as a target of the disease-
associated immune response [35].A destructive inﬂammatory response directed toward a self-
antigen such as mucin, goblet cells, colonocytes and other cells
has been proposed as the underlying basis of UC [36]. The role
of mucosal dysfunction and environmental factors, including
ubiquitous enteric bacteria in acute and chronic intestinal
inﬂammation have been shown by transgenic and knock out
rodent models [37–40]. The mechanisms by which microbes
may play their role in the pathogenesis of UC, includes release
of inﬂammatory mediators inﬂuencing critical cytokine re-
sponses [41,42] and possibly by mimicry related to autoimmu-
nity [43]. The presence of anti-neutrophil cytoplasmic
antibodies in about two thirds of the patients with UC as well
as primary sclerosis cholangitis (PSC), supports autoimmunity
in UC [44,45].
An important contribution in favor of the concept of
autoimmune basis of UC is the observation that human TM
isoform 5 (hTM5), a cytoplasmic protein which is predomi-
nantly expressed in the colon epithelial cells, is a potential
autoantigen associated with UC [46–52]. However, its precise
role in the pathogenesis of UC is yet to be established. If in-
deed, it is responsible for the pathogenesis of UC, is it respon-
sible for the initiation of the disease and/or for its perpetuation
or chronicity?
How do the host eﬀector immune cells see it as an antigen?
While these are some questions that need to be addressed, we
ask if molecular mimicry involving bacterial sequences that
resemble hTM5, is associated with any stage of UC.6. Homologous peptides of hTM5 in bacteria
In pursuit of answers for this question, we looked for se-
quences in bacterial genomes that are homologous to hTM5.
When we searched the NCBI database, we found two bacterial
proteins that have regions of signiﬁcant sequence homology
with hTM5. One of them is a sensor protein, from Bacillus cer-
eus [Accession No. NP_834548]. The other one is a hypothet-
ical protein found in cyanobacteria Nostoc punctiforme [Direct
submission to NCBI, Accession No. ZP_00112434]. While the
sensor protein has a similarity with the C-terminal part of
hTM5, the other protein resembles N-terminal part of hTM5
(Fig. 2). Interestingly, only the N-terminal and C-terminal pep-
tides of hTM5 are found to have signiﬁcant homology with
these bacterial proteins. More interestingly, the sensor protein
from B. cerus is identical to VanS sensor protein anthracis [53].7. Does this sequence homology suggest any role for these
bacteria in the disease process of UC?
Given the signiﬁcant homology in the sequence of peptides
from hTM5 with Nostoc punctiforme and B. cereus, it is
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B. cereus is an opportunistic pathogen causing food poisoning
manifested by diarrhoeal or emetic syndromes. It is closely re-
lated to the animal and human pathogen Bacillus anthracis. In
addition to this, there is a suggestion that a-TM acts as an
autoantigen in Bechets syndrome in in vitro experiments and
in animal models [54]. A structural analysis of 109 autoanti-
gens involved in various autoimmune diseases showed that
majority of them have signiﬁcantly charged coiled-coiled heli-
ces. Interestingly, a-TM has the highest probability of forming
coiled coil conformation and thus has a potential for autoan-
tigenicity [55]. These considerations clearly suggest that
hTM5 has the necessary sequence and structure to be potential
molecular mimic in UC. However, sequence similarity may not
be a suﬃcient condition to qualify TM5 as an initiator of UC.
Therefore, we postulate that, perhaps, hTM5 may be associ-
ated with UC after the initiation stage caused by bacterial
infection. As shown in Fig. 2B, the C-terminal part of hTM5
located between amino acids 188–213 is similar to the peptide
region 120–145 amino acids of sensor protein from B. cerus
and B. anthracis. In addition, to this, the N-terminal part of
hTM5, spanning the amino acids 6–31, is similar to the peptide
region 201–226 of a protein from Nostoc punctiforme (Fig.
2A). The shared epitopes in hTM5 and bacterial proteins de-
scribed in the preceding text may therefore be involved in
molecular mimicry. This is a provocative and testable hypoth-
esis. We realize that our hypothesis is based on sequence sim-
ilarity between hTM5 and bacterial proteins found in the
NCBI database only and therefore, our results from the search
for potential molecular mimics of hTM5, based on amino acid
homology, represent a preliminary observation. An experimen-
tal veriﬁcation of our hypothesis by studies focusing on speciﬁc
immune responses in UC against these two peptides would be
needed and are critical to establish molecular mimicry associ-
ated with hTM5 in UC.
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